Trabecular Bone Score in Multiple Sclerosis

IRCCS Centro Neurolesi "Bonino-Pulejo"

Status: Completed

Conditions: Multiple Sclerosis; Neurologic Disorder; Endocrine System Diseases

Treatments: Diagnostic Test: sm tbs group

Study type: Observational

Funder types: Other

Identifiers

NCT05811689

TBS SM2021

Details and patient eligibility

About

Assess bone quality in MS patients through TBS and evaluate the potential effects exerted by different drugs used in MS treatment, which may affect BMD and TBS in MS patients

Enrollment: 300 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of MS according to the latest revision of McDonald's criteria;
• patients with relapsing-remitting MS (RRMS), secondary progressive MS (SPMS) and primary progressive MS (SPMS);
• absence of cortisone therapy for at least 6 months;

Exclusion criteria

patients already being treated with anti-osteoporotic drugs;

• medical conditions that preclude the execution of the densitometric examination

Trial design

300 participants in 1 patient group

sm tbs group

Description:

All patients will undergo densitometric examination with dual-energy x-ray absorptiometry (DXA) technique at our Facility.

Treatment:

Diagnostic Test: sm tbs group